Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Tal Yalon, M.D., Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thyroid & Parathyroid Surgery: Ask Mayo Clinic Health System
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
"Innovation and Impact: David Vélez on Transforming Brazil's Banking Sector"
00:10:00
Evli Fund Management Company Ltd. introduces Evli Emerging Frontier, focusing on investment opportunities in emerging and frontier markets.
00:10:00
2023 Year-End Financial Planning Webinar: Last Chance Strategies | Bill Bush, Financial Advisor, Horizon Financial Group
00:10:00
IDM Mining's Red Mountain Gold Project: High-Grade Gold Production and Exploration in Northwestern BC - Insights from the One-to-One Mining Investment Conference in New York
00:10:00
GreenRoc Mining CEO Stefan Bernstein Responds to China's Graphite Export Restrictions | Dr. Stefan Bernstein, CEO, GreenRoc Mining PLC.
00:10:00
Hans Wallenstam Reflects on Wallenstam's Strong Growth and Strategic Future | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
The Advisor-Centric Evolution: Insights from Nate Lenz on the Future of Wealth Management | Nate Lenz, CEO and Co-Founder of Concurrent Advisors
00:10:00
Vew funding from so many potential firms|Mary Meeker,General Partner, Bond Capital
00:10:00
Navigating the Challenges: Financial Planning for the Sandwich Generation
00:00:00
Kancera -27 november 2023 - Peter Selin, CEO, Kancera
00:10:00
Mining Investment and Legislation: A Spotlight on the USA
00:10:00
"Unveiling Discretionary Strategies at The D. E. Shaw Group: Where Innovation Meets Responsibility"